| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.6 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |